Principia SGR logo

Principia SGR

Europe, Lombardia, Italy, Milan

Description

Principia is an Italian Venture Capital firm with over Eur 80M under management. Actually Principia has two funds investing in digital

Investor Profile

Principia SGR has made 47 investments, with 0 in the past 12 months and 43% as lead.

Stage Focus

  • Series Unknown (49%)
  • Series A (23%)
  • Seed (11%)
  • Series C (4%)
  • Series B (4%)
  • Debt Financing (2%)
  • Series D (2%)
  • Series E (2%)
  • Convertible Note (2%)

Country Focus

  • Italy (74%)
  • France (9%)
  • United States (6%)
  • United Kingdom (6%)
  • Brazil (2%)
  • Canada (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • E-commerce
  • Life Science
  • Medical Device
  • Biopharma
  • Hardware
  • Advertising
  • Shopping
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Principia SGR frequently co-invest with?

A
Europe, Lombardia, Italy, Milano
Co-Investments: 3
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
dPixel
Europe, Lombardia, Italy, Milan
Co-Investments: 4
Atlante Ventures
Europe, Lombardia, Italy, Milano
Co-Investments: 3
Atlante Seeds
Europe, Lombardia, Italy, Milano
Co-Investments: 4
HF
Europe, Ile-de-France, France, Paris
Co-Investments: 3
F
Europe, Lombardia, Italy, Milan
Co-Investments: 3
Antares Capital
North America, Florida, United States, Miami
Co-Investments: 3
Nestlé Health Science
Europe, Vaud, Switzerland, Vevey
Co-Investments: 3

Which angels does Principia SGR often collaborate with?

PO
Europe, Rhone-Alpes, France, Lyon
Shared Deals: 1
LL
Europe, Lazio, Italy, Rome
Shared Deals: 1
FD
Europe, Lazio, Italy, Roma
Shared Deals: 1

What are some of recent deals done by Principia SGR?

KLISBio

Lomazzo, Lombardia, Italy

Silk-fibroin tissue engineering technology platform

BiotechnologyHealth CareLife ScienceMedical Device
Convertible NoteNov 26, 2021
Amount Raised: $3,396,001
WISE

Milan, Lombardia, Italy

WISE s.r.l is focused on the fabrication and commercial exploitation of electronic and MEMS devices on stretchable supports for apps.

HardwareSoftware
Series COct 1, 2020
Amount Raised: $17,616,075
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
COMPASS Pathways

Altrincham, Cheshire, United Kingdom

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
Series AOct 3, 2018
Amount Raised: $32,350,399
ComfTech s.r.l.

Monza, Lombardia, Italy

ComfTech design and produce sensing garments easy to dress and use for continuous non-intrusive monitoring of biomedical parameters.

BabyElectronicsHealth CareManufacturingMedicalMedical DeviceProduct Design
Series UnknownAug 6, 2018
Amount Raised: $8,091,298
Crest Optics

Rome, Lazio, Italy

Crest Optics, a bioscience startup, produces instruments that use optical and electrooptical technology for scientific and industrial apps.

AppsBiotechnologyOptical Communication
Series UnknownJul 8, 2018
Amount Raised: $7,200,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625

Clinical Trial Center S.P.A. offers clinic research and trial services.

Clinical TrialsHealth Care
Series UnknownAug 12, 2017
WISE

Milan, Lombardia, Italy

WISE s.r.l is focused on the fabrication and commercial exploitation of electronic and MEMS devices on stretchable supports for apps.

HardwareSoftware
Series BMay 25, 2017
Amount Raised: $7,286,563
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390